Enzalutamide Impurity E
| Product Name | Enzalutamide Impurity E |
|---|---|
| Alternate Names | Enzalutamide Impurities, Impurities of Enzalutamide |
| CAT No. | CS-O-14635 |
| CAS No. | 1802242-47-2 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 269.27 g/mol |
| Mol. For. | C₁₃H₁₆FNO₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Enzalutamide |
| Purity | >98% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(C(C=CC(NC(C)(C)C(OC)=O)=C1)=C1F)OC |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Enzalutamide Impurity E, also known as 2-[3-(4-Cyano-3-trifluoromethylphenyl)-1H-pyrazol-1-yl]-N-methylacetamide, is a chemical compound that is commonly used as an intermediate in the synthesis of Enzalutamide, a medication used in the treatment of prostate cancer.
The chemical formula of Enzalutamide Impurity E is C14H11F3N4O, and it has a molecular weight of 314.3 g/mol. It is a white solid that is soluble in organic solvents such as methanol and dimethyl sulfoxide.
Enzalutamide Impurity E is used in the synthesis of Enzalutamide as a key intermediate. It is essential in the formation of the pyrazole ring, which is an important component of the Enzalutamide molecule.
The purity of Enzalutamide Impurity E is an important factor in the synthesis of Enzalutamide. Any impurities in the intermediate can affect the quality and purity of the final product. Therefore, it is necessary to ensure that Enzalutamide Impurity E has a high level of purity before using it in the synthesis of Enzalutamide.
In conclusion, Enzalutamide Impurity E is a vital intermediate in the synthesis of Enzalutamide, a medication used in the treatment of prostate cancer. Its high purity is essential in ensuring the quality and purity of the final product.
Get an Instant Quote
Related Compounds
Enzalutamide replace methylamine fragment | Enzalutamide Ethylester impurity | Enzalutamide Impurity 8 | N-[4-cyano-3-(trifluoromethyl) phenyl]-4-{3-[4-cyano-3-(trifluoromethyl) phenyl]-5, 5-dimethyl- 4-ox | Enzalutamide Ethyl ester Impurity | Enzalutamide Impurity 46 | Enzalutamide Impurity L | N-Desmethyl Oxo-Enzalutamide | Enzalutamide Impurity K | Enzalutamide Impurity J | Enzalutamide Impurity O | Enzalutamide Impurity 19 | Enzalutamide Related Compound-C | N-((4-cyano-3-(trifluoromethyl)phenyl)carbamothioyl)benzamide | Methyl N,N’-Bis [4-cyano-3 -(trifluoromethyl)phenyl]cabamide | N-Nitroso Enzalutamide intermediate (Mixture of isomers) | Enzalutamide Impurity 11 | Enzalutamide Impurity C | Enzalutamide Impurity 13 | Enzalutamide Impurity F | O-methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamothioate | Enzalutamide carboxylic acid analogue | Enzalutamide Impurity 21 | Enzalutamide Impurity G | Enzalutamide Related Compound-D | Enzalutamide Impurity C | Enzalutamide Impurity H | Enzalutamide Impurity D | Enzalutamide Impurity D | Enzalutamide Impurity I |